£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
You Can See More: Cancer treatment: 'Exciting' new drug targets tumours created by faulty BRCA genes
The following article Cancer treatment: 'Exciting' new drug targets tumours created by faulty BRCA genes is courtesy of Daily Express :: Health Feed
£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
Related Posts:
You Can See More: Justin Bieber health: Singer revealed reason for his depression - what are the symptoms?- You Can See More: Borna disease warning: The brain-destroying disease spread by shrews is on the rise
- You Can See More: Natalie J Robb health: Emmerdale actress on what 'scared' her as she reveals health change
- You Can See More: Vitamin B12 deficiency: Sign on the face you’ve taken too much of the supplement
- You Can See More: How to live longer: Drinking UK's favourite drink has been proven to boost life expectancy
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.